Paul Tudor Jones’s WGS Holdings & Trades

First Buy
Q2 2024
Duration Held
6 Quarters
Largest Add
Q2 2024
+91,487 Shares
Current Position
68,654 Shares
$7.4 M Value

Paul Tudor Jones's WGS Position Overview

Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 68,654 shares of GeneDx Holdings Corp. (WGS) worth $7.4 M, representing 0.01% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 6 quarters.

Based on 13F filings, Paul Tudor Jones has maintained this position in WGS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 60,733 shares. Largest reduction occurred in Q1 2025, reducing 93,889 shares.

Analysis based on 13F filings available since 2013 Q2

Paul Tudor Jones's GeneDx Holdings (WGS) Holding Value Over Time

Track share changes against reported price movement

Quarterly GeneDx Holdings (WGS) Trades by Paul Tudor Jones

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2024 +91,487 New Buy 91,487 $26.14
Q3 2024 -30,761 Reduce 33.62% 60,726 $42.44
Q4 2024 +41,084 Add 67.65% 101,810 $76.86
Q1 2025 -93,889 Reduce 92.22% 7,921 $88.56
Q2 2025 -7,921 Sold Out 7,921 $0.00
Q3 2025 +68,654 New Buy 68,654 $107.74

Paul Tudor Jones's GeneDx Holdings Investment FAQs

Paul Tudor Jones first purchased GeneDx Holdings Corp. (WGS) in Q2 2024, acquiring 91,487 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Paul Tudor Jones has held GeneDx Holdings Corp. (WGS) for 6 quarters since Q2 2024.

Paul Tudor Jones's largest addition to GeneDx Holdings Corp. (WGS) was in Q2 2024, adding 91,487 shares worth $2.39 M.

According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 68,654 shares of GeneDx Holdings Corp. (WGS), valued at approximately $7.4 M.

As of the Q3 2025 filing, GeneDx Holdings Corp. (WGS) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.

Paul Tudor Jones's peak holding in GeneDx Holdings Corp. (WGS) was 101,810 shares, as reported at the end of Q4 2024.